Villaruz LC, Blumenschein GR Jr, Otterson GA, Leal TA, et al. Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non-small cell lung cancer. Cancer 2023 Feb 27. doi: 10.1002/cncr.34683.
PMID: 36848319